Trans-species transplants raise virus fears.

Lehrman S

Promega, Roche clash over use of Taq in labs.

Lehrman S, Dickson D

Coalition plans challenge to genetic patenting in the US.

Lehrman S

Chiron expands gene therapy efforts.

Lehrman S

Medical centre cuts staff in preparation for 'managed care'.

Lehrman S

University blocks efforts to reveal researchers' identity.

Lehrman S

US stalls over tests of marijuana to treat AIDS patients.

Lehrman S

Falling stock prices put the squeeze on biotech start-ups.

Lehrman S

Ballot urged on ageing centre plans.

Lehrman S

Lack of significant bronchial reactivity to inhaled normal saline in subjects with a positive methacholine challenge test.

Basir R, Lehrman SG, De Lorenzo LJ, Kalenderian R, Maguire GP

. . . as tighter research links urged.

Lehrman S

Darwin deal marks growth of link-ups for gene companies.

Lehrman S

California law will prohibit genetic discrimination.

Lehrman S

Pearson resigns as head of Darwin Corp.

Lehrman S

Wyden widens net of probe into drug marketing.

Lehrman S